Artificial intelligence is revolutionizing the diagnosis and monitoring of retinal diseases such as AMD and diabetic retinopathy. At IOR, we are implementing the RetinAI platform, which uses advanced algorithms to analyze eye imaging exams, identify early changes, and precisely track patient progress. This technology brings greater speed, safety, and personalized care to vision health, marking a new era in ophthalmology in Recife.